Page 2 - Best Chondrosarcoma doctors: TOP 62 doctors

Dr. Ahmet Bilici is a renowned medical oncologist specializing in sarcoma and lung cancer treatments at Medipol Mega University Hospital.

• 28 years of experience of dedicated experience in oncology
• Expertise in treating rare and complex sarcoma cases
• Recognized as one of Turkey's top sarcoma specialists

Prof. Elke Jaeger is one of Germany's top sarcoma specialists according to Focus rating, with 41 years of experience of practice.

• Head of Oncology and Hematology at Nordwest Clinic
• Recognized as one of Germany's best oncologists
• Specializes in sarcoma treatment

Director of pediatric hematology oncology at Sourasky Medical Center – specializes in bone cancer treatment for children.

• Expert in sarcoma treatment for children
• Trained at Rizzoli Orthopaedic Institute – a world-leading center
• Coordinates bone cancer treatment with oncology-orthopedic teams
• Member of ISPHO – Israel's pediatric hemato-oncology association

Dr. Yildiz specializes in neuroendocrine tumors and has authored 17+ international peer-reviewed articles, including on chondrosarcoma-related conditions.

• Published research on rare tumor cases like paraneoplastic pemphigus and thymoma
• Expertise in diagnosing and managing complex endocrine-related cancers
• Works at Medipol Mega University Hospital – a leading Turkish medical center

Dr. Alemdar specializes in chondrosarcoma at Medical Park Antalya, bringing focused oncology expertise to rare bone cancer cases.

• Board-certified in medical oncology with extensive training
• Experience across multiple prestigious Turkish university hospitals
• Specialized in internal medicine before oncology specialization

Heads a department dedicated to metastatic bone lesions at Ichilov Medical Center – one of Israel's largest hospitals.

• Specializes exclusively in oncological orthopedics, treating bone cancers.
• Completed advanced clinical internships in Israel and the United States.
• Holds a senior academic position as a Professor at Tel Aviv University.
• Educated at the prestigious Hebrew University of Jerusalem.

Dr. Amir is a specialist in limb-sparing surgery for bone and soft tissue cancers at Israel's Sourasky Medical Center (Ichilov).

• Fellowship-trained in orthopedic oncology at the US National Cancer Institute and the University of Toronto
• Active member of the American Musculoskeletal Tumor Society (MSTS) and the International Society of Limb Salvage (ISOLS)
• Multiple award winner, including the Tannenbaum Grant for Excellence in Surgical Oncology
• Focuses on sarcomas, with expertise in complex cases requiring reconstructive techniques

Prof. Köstler specializes in targeted cancer therapies, with over two decades of experience in individualized cancer treatment at Wiener Privatklinik.

• Expert in breast cancer and gynecologic malignancies
• Associate Professor at the Medical University of Vienna
• Focuses on biomarker development and tumor biology
• Active participant in European oncology networks

Professor Keil leads the Clinic for Diagnostic and Interventional Radiology at Academic Hospital Solingen, specializing in advanced imaging for complex cases.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Expert in MRI, CT, and ultrasound-guided interventions
• Former leading doctor at University Hospital of Aachen
• Specializes in cross-sectional imaging for all body regions

Assoc. Prof. Nail Paksoy brings specialized expertise in bone sarcomas from Istanbul University Oncology Institute, now leading chondrosarcoma care at Medipol Bahçelievler Hospital.

• Board-certified in medical oncology by ESMO
• Authored key research on high-dose chemotherapy for Ewing's sarcoma and other bone tumors
• Participated in international trials for NTRK-fusion solid tumors
• Fellowship-trained at one of Turkey's premier oncology centers

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Specializing in virotherapy – one of the newest immunology fields – Dr. Jaunalksne brings 49 years of experience of experience to treating chondrosarcoma.

• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Graduate of Riga Medical Institute with internship in Internal Medicine
• Focuses on innovative immunological approaches to cancer treatment

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).